Algae-Based Biopharmaceuticals

Nonfiction, Science & Nature, Science, Biological Sciences, Botany, Ecology
Cover of the book Algae-Based Biopharmaceuticals by Sergio Rosales-Mendoza, Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Sergio Rosales-Mendoza ISBN: 9783319322322
Publisher: Springer International Publishing Publication: May 21, 2016
Imprint: Springer Language: English
Author: Sergio Rosales-Mendoza
ISBN: 9783319322322
Publisher: Springer International Publishing
Publication: May 21, 2016
Imprint: Springer
Language: English

This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. 

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book constitutes a key reference on the use of algae in the biopharmaceuticals production field; providing an updated outlook on the achievements accomplished thus far and transmitting a prospective view for this biotechnological application.

This book provides a detailed description of the technology as well as an updated outlook of the strides achieved thus far in the field of algae-based biopharmaceuticals. Algae constitute attractive expression hosts for the production of recombinant proteins with medical applications. Among the features that make them attractive candidates are: low cost, fast growth, wide biosynthetic capacity, and absence of human pathogens; which constitute substantial advantages with respect to bacterial and mammalian systems. 

First, the features of algae as convenient hosts for the production of BFs are analyzed in terms of production costs, biosynthetic capacity, and safety (Chapter 1). Second, the genetic engineering tools for algae-species are described. Nuclear and chloroplast-based expression approaches are analyzed and compared in terms of biosynthetic advantages, gene expression complexity, and DNA transfer approaches (Chapter 2). In the following sections, chapters 3 to 7, the state of the art on producing distinct types of BFs in algae species is presented. Although this book is mainly focused on BFs, considering that the production of compounds with health-promoting properties are achieved using genetically-engineered algae strains, chapter 8 deals with nutraceuticals. In the ninth chapter, the developments reported thus far are placed in perspective and challenges for the field are discussed. Critical future prospects comprise the following: optimizing large-scale production in bioreactors, implementing glycoengineering approaches, optimizing nuclear expression, exploring new approaches for oral delivery, and implementing regulatory frameworks to accomplish technology transfer and regulatory approval of algae-made BFs.

More books from Springer International Publishing

Cover of the book Knowledge Management and Acquisition for Intelligent Systems by Sergio Rosales-Mendoza
Cover of the book Provably Correct Systems by Sergio Rosales-Mendoza
Cover of the book Queens Matter in Early Modern Studies by Sergio Rosales-Mendoza
Cover of the book Tools for High Performance Computing 2013 by Sergio Rosales-Mendoza
Cover of the book Bioactive Compounds in Agricultural Soils by Sergio Rosales-Mendoza
Cover of the book Nietzsche’s Culture War by Sergio Rosales-Mendoza
Cover of the book Alien Introgression in Wheat by Sergio Rosales-Mendoza
Cover of the book Seventeenth-Century Indivisibles Revisited by Sergio Rosales-Mendoza
Cover of the book Security Standardisation Research by Sergio Rosales-Mendoza
Cover of the book Organic and Hybrid Solar Cells by Sergio Rosales-Mendoza
Cover of the book Chronic Myeloid Leukemia by Sergio Rosales-Mendoza
Cover of the book Data Driven by Sergio Rosales-Mendoza
Cover of the book Re-Evaluating Regional Organizations by Sergio Rosales-Mendoza
Cover of the book Africa’s Competitiveness in the Global Economy by Sergio Rosales-Mendoza
Cover of the book Hermeneutics and Its Problems by Sergio Rosales-Mendoza
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy